enVVeno Medical Corp (NVNO): R&D Expense
$9.98M
Year ended 2025-12-31
$8.72M
Trailing 12 months to 2026-06-30
+0.2%
3-year compound annual growth
+18.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.98M | -18.5% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $12.25M | -9.8% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $13.58M | +37.0% | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | $9.91M | +73.1% | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | $5.73M | +34.7% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $4.25M | +92.7% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $2.21M | +78.1% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $1.24M | +90.7% | 2020-03-18, From 2018-01-01 |
| 2017-12-31 | $649.7K | n/a | 2019-03-14, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | 2025-12-31 | $9.98M | -18.5% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $435.3K | +43.9% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $642.0K | -5.0% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $100.0K | 0.0% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $14.96M | -15.4% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $10.24M | -39.2% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $1.35M | +101.0% |
Compare NVNO, KRMD, WOK, IDXG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗